These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis and biological evaluation of some pyrrolo[2,3-d]pyrimidines. Rashad AE, Mohamed MS, Zaki ME, Fatahala SS. Arch Pharm (Weinheim); 2006 Dec; 339(12):664-9. PubMed ID: 17149793 [Abstract] [Full Text] [Related]
4. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents. Ghorab MM, Ragab FA, Heiba HI, Youssef HA, El-Gazzar MG. Bioorg Med Chem Lett; 2010 Nov 01; 20(21):6316-20. PubMed ID: 20850308 [Abstract] [Full Text] [Related]
13. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity. Renau TE, Wotring LL, Drach JC, Townsend LB. J Med Chem; 1996 Feb 16; 39(4):873-80. PubMed ID: 8632411 [Abstract] [Full Text] [Related]
14. A new series of HAPs as anti-HBV agents targeting at capsid assembly. Yang XY, Xu XQ, Guan H, Wang LL, Wu Q, Zhao GM, Li S. Bioorg Med Chem Lett; 2014 Sep 01; 24(17):4247-9. PubMed ID: 25127104 [Abstract] [Full Text] [Related]
15. Novel synthesis and antifungal activity of pyrrole and pyrrolo[2,3-d]pyrimidine derivatives containing sulfonamido moieties. El-Gaby MS, Gaber AM, Atalla AA, Abd Al-Wahab KA. Farmaco; 2002 Aug 01; 57(8):613-7. PubMed ID: 12361227 [Abstract] [Full Text] [Related]
16. Novel cytomegalovirus-inhibitory compounds of the class pyrrolopyridines show a complex pattern of target binding that suggests an unusual mechanism of antiviral activity. Hahn F, Hutterer C, Henry C, Hamilton ST, Strojan H, Kraut A, Schulte U, Schütz M, Kohrt S, Wangen C, Pfizer J, Couté Y, Rawlinson WD, Strobl S, Marschall M. Antiviral Res; 2018 Nov 01; 159():84-94. PubMed ID: 30268914 [Abstract] [Full Text] [Related]
17. Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial and antifungal agents. Hilmy KM, Khalifa MM, Hawata MA, Keshk RM, el-Torgman AA. Eur J Med Chem; 2010 Nov 01; 45(11):5243-50. PubMed ID: 20828885 [Abstract] [Full Text] [Related]
18. Synthesis, antiviral, antituberculostic and antibacterial activities of some novel, 4-(4'-substituted phenyl)-6-(4"-hydroxyphenyl)-2-(substituted imino) pyrimidines. Siddiqui AA, Rajesh R, Mojahid-Ul-Islam, Alagarsamy V, Meyyanathan SN, Kumar BP, Suresh B. Acta Pol Pharm; 2007 Nov 01; 64(1):17-26. PubMed ID: 17665846 [Abstract] [Full Text] [Related]
19. Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives and evaluation of their activities against human colon cancer cell lines. Tangeda SJ, Garlapati A. Eur J Med Chem; 2010 Apr 01; 45(4):1453-8. PubMed ID: 20163895 [Abstract] [Full Text] [Related]
20. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines. Renau TE, Kennedy C, Ptak RG, Breitenbach JM, Drach JC, Townsend LB. J Med Chem; 1996 Aug 30; 39(18):3470-6. PubMed ID: 8784444 [Abstract] [Full Text] [Related] Page: [Next] [New Search]